myelodysplastic syndromes (MDS) | Page 115 | Aplastic Anemia and MDS International Foundation

myelodysplastic syndromes (MDS)

Identification of a risk dependent microRNA expression signature in myelodysplastic syndromes.

Author(s): 
Sokol L, Caceres G, Volinia S, Alder H, Nuovo GJ, Liu CG, McGraw K, Clark JA, Sigua CA, Chen DT, Moscinski L, Croce CM, List AF
Primary Author: 
Sokol L
Journal Title: 
Br J Haematol
Original Publication Date: 
Feb 2011

The

Bone Marrow Diseases: 

Epigenetic regulation in myelodysplastic syndromes: implications for therapy.

Author(s): 
Vigna E, Recchia AG, Madeo A, Gentile M, Bossio S, Mazzone C, Lucia E, Morabito L, Gigliotti V, Stefano LD, Caruso N, Servillo P, Franzese S, Fimognari F, Bisconte MG, Gentile C, Morabito F
Primary Author: 
Vigna E
Journal Title: 
Expert Opin Investig Drugs
Original Publication Date: 
Mar 2011

INTRODUCTION:

Bone Marrow Diseases: 

Characteristics and outcome of myelodysplastic syndromes (MDS) with isolated 20q deletion: A report on 62 cases.

Author(s): 
Braun T, de Botton S, Taksin AL, Park S, Beyne-Rauzy O, Coiteux V, Sapena R, Lazareth A, Leroux G, Guenda K, Cassinat B, Fontenay M, Vey N, Guerci A, Dreyfus F, Bordessoule D, Stamatoullas A, Castaigne S, Terré C, Eclache V, Fenaux P, Adès L.
Primary Author: 
Braun T
Journal Title: 
Leuk Res
Original Publication Date: 
Mar 2011

Isolated 20q deletion is common in MDS and considered of good prognosis, but no large series have been reported. We compared characteristics of 62 MDS patients with isolated del 20q, 36 patients with del 20q and other cytogenetic abnormalities, and 1335 MDS patients without del20q. Significant differences between MDS with isolated del 20q and patients

Bone Marrow Diseases: 

Cytogenetics in myelodysplastic syndromes.

Author(s): 
Ohyashiki K, Kodama A, Ohyashiki JH
Primary Author: 
Ohyashiki K
Journal Title: 
Methods Mol Biol
Original Publication Date: 
Jan 2011

Cytogenetic information in patients with myelodysplastic syndrome (MDS) is important in predicting prognosis and therapeutic direction. In MDS, the detection of numerical type abnormalities, either whole chromosome or partial chromosomal segments, is important. In general, conventional banding chromosome analysis is useful in detecting chromosome changes in MDS and is able to predict prognosis.

Bone Marrow Diseases: 

Perceptions of Disease State, Treatment Outcomes, and Prognosis Among Patients with Myelodysplastic Syndromes: Results From an Internet-Based Survey.

Author(s): 
Sekeres MA, Maciejewski JP, List AF, Steensma DP, Artz A, Swern AS, Scribner P, Huber J, Stone R
Primary Author: 
Sekeres MA
Journal Title: 
Oncologist
Original Publication Date: 
Apr 2011

Bone Marrow Diseases: